Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prophylactic pancreas surgery].

P Langer1, M Rothmund, D K Bartsch

  • 1Klinik für Visceral-, Thorax- und Gefässchirurgie der Philipps-Universität Marburg.

Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|November 25, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Controversies in NEN: An ENETS position statement on the management of locally advanced neuroendocrine neoplasia of the small intestine and pancreas without distant metastases.

Journal of neuroendocrinology·2025
Same author

Short-acting urapidil compared to long-acting phenoxybenzamine in the management of pheochromocytoma.

Langenbeck's archives of surgery·2025
Same author

[Gastroenteropancreatic neuroendocrine neoplasms-Surgery in a multimodal concept].

Chirurgie (Heidelberg, Germany)·2024
Same author

Changes in diagnosis and operative treatment of insulinoma over two decades.

Langenbeck's archives of surgery·2023
Same author

Mutation-based, short-term "neoadjuvant" treatment allows resectability in stage IVB and C anaplastic thyroid cancer.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2023
Same author

Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic cancer group.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same journal

[S3 Guideline "Adult soft tissue sarcomas"].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Synopsis-S3 guidelines pancreatic cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Laparoscopic sentinel node navigation surgery in gastric cancer to reduce surgical radicality].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Future concepts for neoadjuvant and adjuvant treatment of (resectable) pancreatic cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[ASCO guidelines for the treatment of stage III NSCLC part 4: indications for adjuvant therapy].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Surgical treatment of pancreatic cancer-What is new?]

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
See all related articles

Prophylactic pancreatic surgery is complex and generally not advised for hereditary tumor syndromes without evidence of malignancy. However, extending resections is recommended if pancreatic endocrine tumors or high-grade lesions are detected.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Genetics

Context:

  • Hereditary tumor predisposition syndromes increase pancreatic cancer risk.
  • Pancreaticoduodenal endocrine tumors (PET) and ductal pancreatic carcinoma (PC) are key concerns.
  • Surgical challenges include high morbidity and mortality, plus post-operative insufficiency.

Purpose:

  • To evaluate the indications for prophylactic pancreatic surgery in hereditary tumor predisposition.
  • To determine when prophylactic resection is advisable for pancreatic endocrine tumors (PET) and pancreatic cancer (PC).

Summary:

  • Prophylactic pancreatic resection is not indicated for PET or PC without diagnosed tumors due to variable penetrance and survival rates.
  • Prophylactic extension of resection is recommended if PET is diagnosed.

Related Experiment Videos

  • For patients predisposed to PC, prophylactic pancreatectomy is not currently advised unless PC or high-grade PanIN lesions are found.

    • Impact:

    • Clarifies surgical decision-making for high-risk individuals.
    • Aims to reduce unnecessary morbidity and mortality associated with prophylactic pancreatectomy.
    • Highlights the need for individualized risk assessment in hereditary pancreatic cancer syndromes.